Skip to main content
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 1999 Dec 29;354(1392):1985–1994. doi: 10.1098/rstb.1999.0538

Drugs for a new millennium.

S H Snyder 1
PMCID: PMC1692706  PMID: 10670019

Abstract

A millennium, a century, even a decade is a long time-frame for speculation about anything. Advances in biomedical research in the last few decades have been so extraordinary and escalating at an ever-accelerating pace that any prophecy is a risky proposition. However, it is possible to divine the big, unanswered questions and envisage ways in which they might reasonably be approached in the next few decades, a task which I will try to essay. So many drugs treat so many different medical conditions that a detailed and comprehensive coverage would probably be tiresome. Instead, I will address certain broad themes and diseases that offer both immense challenges and great potential for advances. Rather than review detailed experimental issues, I will confine myself to the 'big picture' issues, providing examples of specific research only in a few instances drawing largely from areas I know best.

Full Text

The Full Text of this article is available as a PDF (264.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1988 Sep;1(3):179–186. doi: 10.1016/0893-133x(88)90012-7. [DOI] [PubMed] [Google Scholar]
  2. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease. Trends Neurosci. 1990 Jul;13(7):272–276. doi: 10.1016/0166-2236(90)90108-m. [DOI] [PubMed] [Google Scholar]
  3. Kitayama S., Morita K., Dohi T., Wang J. B., Davis S. C., Uhl G. R. Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells. Ann N Y Acad Sci. 1996 Oct 31;801:388–393. doi: 10.1111/j.1749-6632.1996.tb17460.x. [DOI] [PubMed] [Google Scholar]
  4. Lipton S. A., Rosenberg P. A. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994 Mar 3;330(9):613–622. doi: 10.1056/NEJM199403033300907. [DOI] [PubMed] [Google Scholar]
  5. Pieper A. A., Verma A., Zhang J., Snyder S. H. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci. 1999 Apr;20(4):171–181. doi: 10.1016/s0165-6147(99)01292-4. [DOI] [PubMed] [Google Scholar]

Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES